federal_register: 03-29333

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
03-29333 Determination of Regulatory Review Period for Purposes of Patent Extension; XIGRIS Notice The Food and Drug Administration (FDA) has determined the regulatory review period for XIGRIS and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of three applications to the Director of Patents and Trademarks, Department of Commerce, for the extension of three patents which claim that human biological product. 2003-11-25 2003 11 https://www.federalregister.gov/documents/2003/11/25/03-29333/determination-of-regulatory-review-period-for-purposes-of-patent-extension-xigris https://www.govinfo.gov/content/pkg/FR-2003-11-25/pdf/03-29333.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) has determined the regulatory review period for XIGRIS and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of three applications to the...

Links from other tables